Bloomington, Minn., retiree Jim Furber considers Medtronic a great asset to the state and says he’s thankful for the company’s growth and stock appreciation over the years. But like many Minnesotans who proudly invested in the homegrown company years ago, the former manufacturer’s rep feels blindsided by an unexpected tax bill from Medtronic’s proposed $42.9 billion takeover of Covidien.
Medtronic deal could sting for long-time shareholders
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.